Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement from the American Heart Association and American College of Cardiology

Circulation

Volumn 132, Issue 22, 2015, Pages e330-e333

  Estes, N A Mark ^a   Kovacs, Richard J ^b   Baggish, Aaron L ^c   Myerburg, Robert J ^d  

^a TUFTS UNIVERSITY   (United States)

^b INDIANA UNIVERSITY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF MIAMI   (United States)

Author keywords

AHA Scientific Statements; athletes; cardiovascular abnormalities; drugs; performance enhancing substances

Indexed keywords

ANABOLIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CANNABINOID; CARDIOVASCULAR AGENT; DIURETIC AGENT; ERYTHROPOIETIN; GLUCOCORTICOID; NARCOTIC AGENT; PERFORMANCE ENHANCING SUBSTANCE; TESTOSTERONE;

ARTICLE; ATHLETE; CLINICAL PRACTICE; DOPING; LAW; MEDICAL SOCIETY; PRIORITY JOURNAL; SUBSTANCE ABUSE; ADVISORY COMMITTEE; CARDIOLOGY; CARDIOVASCULAR ABNORMALITIES; HUMAN; PRACTICE GUIDELINE; PROCEDURES; STANDARDS; UNITED STATES;

ADVISORY COMMITTEES; AMERICAN HEART ASSOCIATION; ATHLETES; CARDIOLOGY; CARDIOVASCULAR ABNORMALITIES; HUMANS; PERFORMANCE-ENHANCING SUBSTANCES; PRACTICE GUIDELINES AS TOPIC; UNITED STATES;

EID: 84949322934     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0000000000000247     Document Type: Article

References (12)

1. World Anti-Doping Agency (WADA) Code Web site. https://www.wadaama. org/en/. Accessed August 24, 2015.
2. List of prohibited substances and methods. World Anti-Doping Agency (WADA) Web site. Available at: https://www.wada-ama.org/en/what-wedo/prohibited-list. Accessed December 24, 2014.
3. Estes NAM 3rd, Kloner R, Olshansky B, Virmani R. Task Force 9: drugs and performance-enhancing substances. J Am Coll Cardiol. 2005;45:1368-1369.
4. World Anti-Doping Code. World Anti-Doping Agency (WADA) Web site. https://www.wada-ama.org/en/what-we-do/the-code. Accessed March 3, 2013.
5. Deligiannis A, Björnstad H, Carre F, Heidbüchel H, Kouidi E, Panhuyzen-Goedkoop NM, Pigozzi F, Schänzer W, Vanhees L; ESC Study Group of Sports Cardiology. ESC Study Group of Sports Cardiology position paper on adverse cardiovascular effects of doping in athletes. Eur J Cardiovasc Prev Rehabil. 2006;13:687-694. doi: 10.1097/01. hjr.0000224482.95597.7a.
6. Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, Bunnell TJ, Tricker R, Shirazi A, Casaburi R. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996;335:1-7. doi: 10.1056/NEJM199607043350101.
7. ClinicalTrials.gov registry and results database. http://clinicaltrials.gov/. Accessed March 3, 2013.
8. Dhar R, Stout CW, Link MS, Homoud MK, Weinstock J, Estes NA 3rd. Cardiovascular toxicities of performance-enhancing substances in sports [published correction appears in Mayo Clin Proc. 2006;81:133]. Mayo Clin Proc. 2005;80:1307-1315. doi: 10.4065/80.10.1307.
9. FDA acts to remove ephedra-containing dietary supplements from market [news release]. Silver Spring, MD; US Food and Drug Administration; November 23, 2004. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2004/ucm108379.htm. Accessed August 26, 2014.
10. Kratochvil CJ, Vaughan BS, Barker A, Corr L, Wheeler A, Madaan V. Review of pediatric attention deficit/hyperactivity disorder for the general psychiatrist. Psychiatr Clin North Am. 2009;32:39-56. doi: 10.1016/j. psc.2008.10.001.
11. Isner JM, Estes NA 3rd, Thompson PD, Costanzo-Nordin MR, Subramanian R, Miller G, Katsas G, Sweeney K, Sturner WQ. Acute cardiac events temporally related to cocaine abuse. N Engl J Med. 1986;315:1438-1443. doi: 10.1056/NEJM198612043152302.
12. International Standard for Therapeutic Use Exemptions (ISTUE). World Anti-Doping Agency (WADA) Web site. https://www.wada-ama.org/en/resources/therapeutic-use-exemption-tue/international-standard-for-therapeutic-use-exemptions-istue. Accessed August 24, 2015.